J&J submits gastric band PMA
This article was originally published in The Gray Sheet
Johnson & Johnson's Ethicon Endo-Surgery subsidiary files a PMA application April 9 for its laparoscopic adjustable gastric band to treat morbid obesity. The FDA submission includes a 276-patient, multi-center, single-arm study examining patients' percent weight loss three years after band placement. The device, marketed outside the United States as the Swedish Adjustable Gastric Band since 1996, is used in 25,000 procedures each year, according to Ethicon. Allergan's Lap-Band, FDA approved in 2001, is the only laparoscopic adjustable gastric band available in the United States (1"The Gray Sheet" March 19, 2007, p. 14)...
You may also be interested in...
CMS' decision to cover Allergan's Lap-Band laparoscopic adjustable gastric band for Medicare beneficiaries last February helped spark a 33% revenue jump for Allergan's obesity intervention business in 2006
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.